First Horizon Corporation’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
Other funds holding DNTH
First Horizon Corporation's DNTH Position: Q3 2026 in Review
First Horizon Corporation held its Dianthus Therapeutics (DNTH) position steady in Q3 2026 at 409 shares worth $36K. The position accounts for ﹤0.01% of the portfolio, ranked #744.
First Horizon Corporation first reported a position in DNTH in Q1 2026 and has held it in 3 quarters since. The position peaked at $39.9K in Q2 2026. 275 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.
- First Horizon Corporation held 409 shares of Dianthus Therapeutics worth $36K as of Q3 2026.
- First Horizon Corporation left its Dianthus Therapeutics share count unchanged in Q3 2026.
- Dianthus Therapeutics made up ﹤0.01% of First Horizon Corporation's portfolio in Q3 2026, its #744 holding.
- First Horizon Corporation first reported a position in Dianthus Therapeutics in Q1 2026 and has held it in 3 quarters since.
- First Horizon Corporation's Dianthus Therapeutics position peaked at $39.9K in Q2 2026.
- 275 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.
Based on First Horizon Corporation's 13F filing for Q3 2026, filed 26 Oct 2026.